Abstract PO2-25-04: Anti-TIGIT upregulate CD226 on CD8+T cell as a potential therapeutic manner in HER2 positive breast cancer

Authors: Liyi Zhang, Qi Zhang, Zehao Wang, Zhibo Shao, Jingyan Xue, Yayun Chi, Bingqiu Xiu, Jiong Wu

Published: 2024-05-02

DOI: 10.1158/1538-7445.sabcs23-po2-25-04

Source: Full article